However, reducing c-MYC expression alone induces tumor regression in mouse models of PDAC (Vaseva et al., 2018; Tsang et al., 2017); therefore, determining whether reducing c-MYC expression confers sensitivity to T/CQ is technically challenging. The gene discussed is MYC; the disease is neoplasm.